USANA Health Sciences Inc... (USNA)
Bid | 27.36 |
Market Cap | 553.54M |
Revenue (ttm) | 876.24M |
Net Income (ttm) | 34.92M |
EPS (ttm) | 1.82 |
PE Ratio (ttm) | 16.13 |
Forward PE | 9.07 |
Analyst | Hold |
Ask | 30.6 |
Volume | 164,915 |
Avg. Volume (20D) | 235,897 |
Open | 28.33 |
Previous Close | 28.04 |
Day's Range | 28.27 - 29.69 |
52-Week Range | 23.10 - 49.78 |
Beta | 1.00 |
About USNA
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; a...
Analyst Forecast
According to 1 analyst ratings, the average rating for USNA stock is "Hold." The 12-month stock price forecast is $36, which is an increase of 22.66% from the latest price.
Stock Forecasts
2 months ago · seekingalpha.com
USANA Health Sciences, Inc. (USNA) Q4 2024 Earnings Conference Call TranscriptUSANA Health Sciences, Inc. (NYSE:USNA ) Q4 2024 Earnings Conference Call February 26, 2025 11:00 AM ET Company Participants Andrew Masuda - IR Jim Brown - President and CEO Brent Neidig - Chief Comme...